Clinical and Metabolic Findings in a Patient with Phytosterolaemia

Sigurdsson G Nicoll A Lewis B. The metabolism of low density lipoprotein in endogenous hypertriglyceridaemia. Eur J Clin Invest 1976; 6: 151–8.

Mount JN Kearney EM Rosseneu M Slavin B. Immunoturbidimetric assays for serum apolipoproteins A-I and B using the Cobas-Bio centrifugal analyser. J Clin Path 1986; 41: 471–4.

Bilheimer DW Ho YK Brown MS Anderson RGW Goldstein J. Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolaemia. J Clin Invest 1978; 61: 678–96.

Grundy SM Ahrens EH Miettinen TA . Quantitative isolation and gas-liquid chromatographic analysis of total fecal bile acids. J Lipid Res 1965; 6: 397–410.

Durrington PN , ed. Normal serum lipid and lipoprotein concentrations. In: Hyperlipidaemia. Diagnosis and Management. London: Wright 1989; 56–68.

Janus ED Nicoll AM Turner P Magill P Lewis B. Kinetic bases of the primary hyperlipidaemias: Studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest 1980; 10: 161–72.

International Collaborative Study Group. Metabolic epidemiology of plasma cholesterol. Lancet 1986; ii: 991–6.

Salen G Shefer S Berginer VH . Familial diseases with storage of sterols other than cholesterol: Cerebrotendinous xanthomatosis and sitosterolaemia with xanthomatosis. In: Stanbury JB Wyngarden JB Frederickson DS Brown MS Goldstein JL . (eds). The Metabolic Basis of Inherited Disease, 5th edn. New York: McGraw-Hill 1983; 724–8.

Study Group, European Atherosclerosis Society. Strategies for the prevention of coronary heart disease: A policy statement of the European Atherosclerosis Society. Eur Heart J 1987; 8: 77–88.

Shepherd J Betteridge DJ Durrington P Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: Guidelines of the British Hyperlipidaemia Association. Br Med J 1987; 295: 1245–6.

Smith EB . Intimal and medial lipids in human aortas. Lancet 1960; i: 799–803.

Salen G Horak I Rothkopf M Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolaemia with xanthomatosis. J Lipid Res 1985; 26: 1126–33.

Bhattacharyya A Connor WE . β-sitosterolaemia with xanthomatosis: A newly described lipid storage disease in two sisters. J Clin Invest 1974; 53: 1033–43.

Bjorkhem I Skrede S. Familial diseases with storage of sterols other than cholesterol: Cerebrotendinous xanthomatosis and phytosterolaemia. In: Scriver CR Beandet AL Sly WS Valle D . (eds). The Metabolic Basis of Inherited Disease, 6th edn. New York: McGraw-Hill 1989; 1293–9.

Belamarich PF Deckelbaum RJ Starc TJ Dobrin BE Tin GS Salen G. Response to diet and cholestyramine in a patient with sitosterolaemia. Paediatrics 1990; 86: 977–81.

Grundy SM . Cerebrotendinous xanthomatosis. N Eng J Med 1984; 311: 1694–5.

Salen G Kwiterovitch PO Shefer S Increased plasma cholestanol and 5-saturated plant sterol derivatives in subjects with sitosterolaemia and xanthomatosis. J Lipid Res 1985; 26: 203–9.

Brunzell JD Sniderman A Albers JJ Kwiterovitch PO . Apoproteins B and A-I and coronary heart disease in humans. Atherosclerosis 1984; 4: 79–83.

Kwiterovitch PO Bachorik PS Smith HH Hyperapobetalipoproteinaemia in two families with xanthomas and phytosterolaemia. Lancet 1981; i: 466–9.

Janus ED Nicoll AM Wooton R Turner PR Magill PJ Lewis B. Quantitative studies of very low density lipoprotein conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoproteins in heterozygous familial hypercholesterolaemia. Eur J Clin Invest 1980; 10: 149–59.

Miettinen TA . Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: A case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur J Clin Invest 1980; 10: 27–35.

Lin HJC Wang C Salen G Lam KC Chan TK . Sitosterol and cholesterol metabolism in a patient with sitosterolaemia and xanthomatosis. Metabolism 1983; 32: 126–33.

Brown MS Goldstein JL . Receptor mediated control of cholesterol metabolism. Science 1976; 191: 150–4.

Grundy SM Ahrens EH Salen G. Interruption of the enterohepatic circulation of bile acids in man: Comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J Lab Clin Med 1971; 78: 94–121.

Shepherd J Packard CJ Bicker S Lawrie TDV Morgan HG . Cholestyramine promotes receptor-mediated low density lipoprotein catabolism. N Eng J Med 1980; 302: 1219–22.